Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy-Reference-Cited by-同舟云学术

Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy

Published:2014-07-28 Issue:2 Volume:114 Page:193-201
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lammers Rianne J.M.¹,Palou Joan²,Witjes Wim P.J.¹³,Janzing-Pastors Maria H.D.³,Caris Christien T.M.³,Witjes J. Alfred¹

Affiliation:

1. Department of Urology; RadboudUMC; Nijmegen The Netherlands

2. Oncology Urology; Fundacio Puigvert; Barcelona Spain

3. CuraTrial SMO and Research; Arnhem The Netherlands

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12495/fullpdf

Reference31 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

4. Guideline for the management of non muscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

5. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model;Fernandez-Gomez;J Urol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT;Health Technology Assessment;2022-10

2. Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms;best practice onkologie;2022-05

3. Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms;Der Urologe;2021-10-15

4. Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel;European Urology Focus;2020-05

5. External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system;Urologic Oncology: Seminars and Original Investigations;2020-02